Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Excipients Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
The global pharmaceutical excipients market is expected to decline from $6.41 billion in 2019 to $6.12 billion in 2020 at a compound annual growth rate (CAGR) of -4.62%.
Pharmaceutical Excipients Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical excipients market.
Major players in the pharmaceutical excipients market are, Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International Plc, Ashland, BASF SE, The Lubrizol Corporation, and Roquette Freres.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.67 billion in 2023 at a CAGR of 7.84%.
The pharmaceutical excipients market consists of sales of pharmaceutical excipients and related services. The excipient is a substance, not an active pharmaceutical ingredient (API) that has been evaluated for safety, and intentionally added in a drug delivery system. Excipient's major roles are to protect, support, enhance stability, bioavailability, patient acceptability, and assist in the effectiveness. The market consists of revenue generated by the companies manufacturing the pharmaceutical excipients by the sales of these excipients.
In December 2018, Roquette, a global manufacturer of plant-based excipients, acquired the majority stake in Crest Cellulose for an undisclosed amount. This acquisition will increase Roquette's footprint in India and expand its portfolio. Crest Cellulose is an India-based excipient manufacturer.
The pharmaceutical excipients market covered in this report is segmented by functionality into fillers and diluents; suspending and viscosity agents; coating agents; binders; flavouring agents and sweeteners; disintegrants; colorants; lubricants and glidants; others, and by type of formulation into oral formulation; topical formulation; parental formulation.
Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. According to the Pharmaceutical Journal, there are certain complications in children with the use of pharmaceutical drugs with excipients. For instance, the colorants used in medicine as a coloring agent may lead to sensitivity reactions and hyperactive behavior in children.
Ethanol is another solvent that is widely used in an oral liquid formulation, the use of ethanol mixed medicine for children may have a risk of acute intoxication when overdose, and it may lead chronic toxicity with long term use. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market.
The increase in research and development in the pharmaceutical formulation to enhance the production process and product quality by using multi-functional excipients is a trend shaping the market. Excipients play a significant role in helping pharmaceutical manufacturers better support patients by increasing compliance and treatment effectiveness.
For instance, Evonik's newly launched EUDRAGIT FS 100 is a solid version of the existing EUDRAGIT FS 30 D. This new multi-functional version allows pharmaceutical companies to use the polymer in many new applications, such as hot-melt extrusion, solvent spray-drying, and solvent coating, which was impossible to achieve in past decades where only the aqueous version was available.
The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market. Generic drugs are alternatives to the marketed brand name drug in the same dosage form, safety, strength, and route of administration and quality.
According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines; the country's generic drugs account for 20% of the global generic drug exports. Indian pharmaceutical companies received 300 generic drug approvals in the USA during 2017. The surge in the demand for generic drugs drives the pharmaceutical excipients market.
Key Topics Covered:
1. Executive Summary
2. Pharmaceutical Excipients Market Characteristics
3. Pharmaceutical Excipients Market Size And Growth
3.1. Global Pharmaceutical Excipients Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Pharmaceutical Excipients Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Pharmaceutical Excipients Market Segmentation
4.1. Global Pharmaceutical Excipients Market, Segmentation By Functionality, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Fillers and Diluents
Suspending and Viscosity Agents
Flavouring Agents and sweeteners
Lubricants and Glidants
4.2. Global Pharmaceutical Excipients Market, Segmentation By Type of Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Pharmaceutical Excipients Market Regional And Country Analysis
5.1. Global Pharmaceutical Excipients Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Pharmaceutical Excipients Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Archer Daniels Midland Co.
Associated British Foods
Dow Chemical Company
Croda International Plc
The Lubrizol Corporation
Kerry Group Plc
Avantor Performance Materials
Merck & Co
Eastman Chemical Corporation
Shin-Etsu Chemical Co.
Chemische Fabrik Budenheim
Peter Greven GmbH & Co. KG
For more information about this report visit https://www.researchandmarkets.com/r/r6x4uk
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900